Searle, D. E., Knurowski, T., Gooding, S., Campbell, V., Moore, S., Chaidos, A., Travers, J., Creasey, T., Clegg, K., Somervaille, T., Pawlyn, C. (2025). Evaluating inobrodib (CCS1477) in combination with teclistamab or elranatamab in patients with Relapsed/Refractory multiple myeloma; Specific cohorts within a Phase I/IIa study evaluating inobrodib in patients with advanced hematological malignancies. Blood. https://doi.org/10.1182/blood-2025-8242